ReviewDrugs2021
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents.
Sho Hasegawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
48 papers cite it
this papertrialcites it
ReviewDrugs2021
Sho Hasegawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.